Business
US pharma company Eli Lilly pauses trial of antibody drug Trump touted as COVID-19 ‘cure’ – Sydney Morning Herald
Eli Lilly’s announcement comes one day after Johnson & Johnson said it was forced to pause a large high-profile trial of its experimental coronavirus vaccine be…
Lilly said earlier this month it was applying for emergency use authorisation (EUA) for the antibody drug, LY-CoV555, for patients with mild to moderate COVID-19 based on data from another clinical trial.
It is not uncommon to pause drug trials to investigate safety concerns, and such actions do not necessarily indicate a serious problem. Because of the urgent need for drugs and vaccines to tackle a pandemic that has claimed over 1 million lives worldwide – and the speed with which they are bei…
-
Noosa News9 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
General12 hours agoHomicide Squad investigating ‘suspicious’ death of 84yo woman in Sydney suburb of Melonba
-
General24 hours agoNewcastle Jets defeat semi-professional Heidelberg United 3-1 to lift first Australia Cup
-
General13 hours agoEnglish springer spaniels Kelly and Milo helping fight dieback in Western Australia